Kelly Westbrook

614 total citations
28 papers, 338 citations indexed

About

Kelly Westbrook is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kelly Westbrook has authored 28 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kelly Westbrook's work include Breast Cancer Treatment Studies (7 papers), Cancer survivorship and care (6 papers) and Advanced Breast Cancer Therapies (5 papers). Kelly Westbrook is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Cancer survivorship and care (6 papers) and Advanced Breast Cancer Therapies (5 papers). Kelly Westbrook collaborates with scholars based in United States, United Kingdom and Australia. Kelly Westbrook's co-authors include Vered Stearns, Laura S. Porter, Francis J. Keefe, Linda Sanders, Kimberly M. Carson, James W. Carson, Maren K. Olsen, Heather Moore, Lee W. Jones and Saundra S. Buys and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Kelly Westbrook

26 papers receiving 336 citations

Peers

Countries citing papers authored by Kelly Westbrook

Since Specialization

Citations

This map shows the geographic impact of Kelly Westbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Westbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Westbrook more than expected).

Fields of papers citing papers by Kelly Westbrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Westbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Westbrook. The network helps show where Kelly Westbrook may publish in the future.

Co-authorship network of co-authors of Kelly Westbrook

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Westbrook. A scholar is included among the top collaborators of Kelly Westbrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Westbrook. Kelly Westbrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survival outcomes after pathologic complete response with neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy: a retrospective national database study 2025 ·Breast Cancer Research and Treatment ·(unknown), Samantha M. Thomas, Ian Halliday, Astrid Botty van den Bruele, Akiko Chiba, (unknown), (unknown), Maggie L. DiNome, Kelly Westbrook, Jennifer K. Plichta	1
2	Examining inequities associated with incarceration among breast cancer patients 2024 ·Cancer Medicine ·Yoshiko Iwai, Alice Yunzi L. Yu, Samantha Thomas, (unknown), Kelly Westbrook, Andrea K. Knittel, Oluwadamilola M. Fayanju	2
3	Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with immunotherapy in early-stage triple-negative breast cancer 2024 ·Breast Cancer Research and Treatment ·(unknown), Susan Dent, Kelly Westbrook, Hui‐Jie Lee, (unknown), Heather Moore	2
4	Efficacy of a couple‐based intervention addressing sexual concerns for breast cancer survivors: Results of a randomized controlled trial 2024 ·Cancer ·Jennifer Barsky Reese, Stephen J. Lepore, Kristen A. Sorice, Lauren A. Zimmaro, (unknown), Elizabeth A. Handorf, (unknown), Alexandra K. Zaleta, Kelly Westbrook, Laura S. Porter	0
5	Cardiovascular impact of near complete estrogen deprivation in premenopausal women with breast cancer: The CROWN study 2023 ·American Heart Journal ·Alexandra Thomas, Nathaniel S. O’Connell, (unknown), (unknown), Carolyn J. Park, Susan Dent, (unknown), Igor Klem, (unknown), Kelly Westbrook, W. Gregory Hundley, Wendy Bottinor, Mary Helen Hackney, Karl Richardson, Sherona Sirkisoon, Ralph B. D’Agostino, Jennifer H. Jordan	2
6	Real-World Perspectives and Practices for Pneumonitis/Interstitial Lung Disease Associated With Trastuzumab Deruxtecan Use in Human Epidermal Growth Factor Receptor 2–Expressing Metastatic Breast Cancer 2023 ·JCO Oncology Practice ·Hope S. Rugo, (unknown), Yaron Gesthalter, (unknown), Heather Moore, Mothaffar F. Rimawi, Kelly Westbrook, Saundra S. Buys	37
7	Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer 2023 ·Annals of Surgical Oncology ·(unknown), Yu Ren, Jennifer K. Plichta, Laura H. Rosenberger, (unknown), Maggie L. DiNome, Kelly Westbrook, E. Shelley Hwang	3
8	Evaluation of alpelisib-induced hyperglycemia prophylaxis and associated risk factors in PIK3CA-mutated hormone-receptor positive, human epidermal growth factor-2 negative advanced breast cancer 2022 ·Breast Cancer Research and Treatment ·(unknown), (unknown), Hui‐Jie Lee, Jeremy Force, Kelly Westbrook, Heather Moore	4
9	253P Risk factor (RF) identification (ID) and hyperglycemia (HG) prevention with alpelisib (ALP) + fulvestrant (FLV) in PIK3CA-mutated, hormone-receptor positive (HR+), human epidermal growth factor-2 negative (HER2-) advanced breast cancer (ABC) 2021 ·Annals of Oncology ·(unknown), (unknown), HJ Lee, Jeremy Force, Kelly Westbrook, Harvey G. Moore	4
10	Evaluating a couple-based intervention addressing sexual concerns for breast cancer survivors: study protocol for a randomized controlled trial 2020 ·Trials ·Jennifer Barsky Reese, Lauren A. Zimmaro, Stephen J. Lepore, Kristen A. Sorice, Elizabeth A. Handorf, Mary B. Daly, Leslie R. Schover, Deborah A. Kashy, Kelly Westbrook, Laura S. Porter	24
11	293P Impact of tucatinib on progression free survival in patients with HER2+ metastatic breast cancer and stable or active brain metastases 2020 ·Annals of Oncology ·Thomas Bachelot, NU Lin, (unknown), Sara A. Hurvitz, (unknown), Mafalda Oliveira, Catherine Oakman, Sajid Khan, Cynthia A. Lynch, Kelly Westbrook, Catherine Doyle, Mattea Reinisch, Marco Colleoni, DJ Slamon, G. N. Hortobagyi, EP Winer, Suzanne McGoldrick, Xin An, Sibylle Loibl	9
12	Yoga Practice Predicts Improvements in Day-to-Day Pain in Women With Metastatic Breast Cancer 2020 ·Journal of Pain and Symptom Management ·James W. Carson, Kimberly M. Carson, Maren K. Olsen, Linda Sanders, Kelly Westbrook, Francis J. Keefe, Laura S. Porter	18
13	Abstract P3-08-10: Characterization of oncotype DX recurrence score and chemotherapy utilization patterns in young women (≤40) with early stage ER+/HER-, lymph node negative breast cancer 2020 ·Cancer Research ·Sarah Sammons, Yi Ren, Jeremy Force, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Jennifer K. Plichta, Gretchen Kimmick, Kelly Westbrook, Susan Dent, Carey K. Anders, Samantha M. Thomas, Terry Hyslop, E. Shelley Hwang, P. Kelly Marcom, Rachel A. Greenup	1
14	Four Conversations : A Randomized Controlled Trial of an Online, Personalized Coping and Decision Aid for Metastatic Breast Cancer Patients 2019 ·Journal of Palliative Medicine ·Sophia K. Smith, Kelly Westbrook, (unknown), (unknown), (unknown), Wei Pan	9
15	The impact of chemotherapy sequence on survival in node‐positive invasive lobular carcinoma 2019 ·Journal of Surgical Oncology ·Nina Tamirisa, (unknown), Samantha M. Thomas, Kelly Westbrook, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Terry Hyslop, (unknown), Oluwadamilola M. Fayanju	11
16	Feasibility of a mindful yoga program for women with metastatic breast cancer: results of a randomized pilot study 2019 ·Supportive Care in Cancer ·Laura S. Porter, James W. Carson, Maren K. Olsen, Kimberly M. Carson, Linda Sanders, Lee W. Jones, Kelly Westbrook, Francis J. Keefe	51
17	Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype 2018 ·Clinical Breast Cancer ·Jeremy Force, Lynn Howie, Sara Abbott, Rex C. Bentley, P. Kelly Marcom, Gretchen Kimmick, Kelly Westbrook, Sarah Sammons, (unknown), (unknown), Ryan Emerson, Gloria Broadwater, Terry Hyslop, Kimberly Blackwell, Smita K. Nair	22
18	Links Between Communication and Relationship Satisfaction Among Patients With Cancer and Their Spouses: Results of a Fourteen-Day Smartphone-Based Ecological Momentary Assessment Study 2018 ·Frontiers in Psychology ·Shelby L. Langer, Joan M. Romano, Michael Todd, Timothy J. Strauman, Francis J. Keefe, Karen L. Syrjala, Jonathan B. Bricker, (unknown), John W. Burns, Niall Bolger, (unknown), Julie R. Gralow, Veena Shankaran, Kelly Westbrook, S. Yousuf Zafar, Laura S. Porter	35
19	Pharmacogenomics of breast cancer therapy: An update 2013 ·Pharmacology & Therapeutics ·Kelly Westbrook, Vered Stearns	32
20	Risk factors for requiring cataract surgery following total body irradiation 1994 ·Radiotherapy and Oncology ·Kathryn Fife, S Milan, Kelly Westbrook, R Powles, Diana Tait	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact